$REFI
Chicago Atlantic Real Estate Finance, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024122763 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $16.26M
YoY Change 7.11%
Cost Of Revenue $1.799M
YoY Change 24.09%
Gross Profit $14.46M
YoY Change 5.31%
Gross Profit Margin 88.93%
Selling, General & Admin $4.237M
YoY Change 9.21%
% of Gross Profit 29.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.248M
YoY Change -15.42%
Operating Profit $11.21M
YoY Change 13.36%
Interest Expense $1.799M
YoY Change 24.17%
% of Operating Profit 16.05%
Other Income/Expense, Net
YoY Change
Pretax Income $11.21M
YoY Change 12.37%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $11.21M
YoY Change 12.37%
Net Earnings / Revenue 68.96%
Basic Earnings Per Share $0.57
Diluted Earnings Per Share $0.56
COMMON SHARES
Basic Shares Outstanding 19.63M 19.62M
Diluted Shares Outstanding 20.06M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.760M
YoY Change -22.29%
Cash & Equivalents $6.760M
Short-Term Investments
Other Short-Term Assets $1.472M
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $8.847M
YoY Change -31.42%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets -$4.091M
YoY Change -19.79%
Total Long-Term Assets $357.1M
YoY Change 5.2%
TOTAL ASSETS
Total Short-Term Assets $8.847M
Total Long-Term Assets $357.1M
Total Assets $365.9M
YoY Change 3.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.358M
YoY Change 13.14%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.29M
YoY Change 7.85%
LONG-TERM LIABILITIES
Long-Term Debt $54.00M
YoY Change -14.29%
Other Long-Term Liabilities $4.151M
YoY Change 88.7%
Total Long-Term Liabilities $58.15M
YoY Change -10.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.29M
Total Long-Term Liabilities $58.15M
Total Liabilities $70.45M
YoY Change -7.94%
SHAREHOLDERS EQUITY
Retained Earnings -$4.452M
YoY Change 231.57%
Common Stock $299.9M
YoY Change 8.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $295.5M
YoY Change
Total Liabilities & Shareholders Equity $365.9M
YoY Change 3.86%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $11.21M
YoY Change 12.37%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $8.203M
YoY Change 720.3%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $23.54M
YoY Change -208.43%
Cash From Investing Activities $23.54M
YoY Change -208.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -32.05M
YoY Change -381.67%
NET CHANGE
Cash From Operating Activities 8.203M
Cash From Investing Activities 23.54M
Cash From Financing Activities -32.05M
Net Change In Cash -310.5K
YoY Change -96.67%
FREE CASH FLOW
Cash From Operating Activities $8.203M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001867949
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q3 refi Change In Unrealized Loss On Debt Securities At Fair Value
ChangeInUnrealizedLossOnDebtSecuritiesAtFairValue
CY2024Q3 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
CY2023Q3 us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41123
dei Entity Registrant Name
EntityRegistrantName
CHICAGO ATLANTIC REAL ESTATE FINANCE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-3125132
dei Entity Address Address Line1
EntityAddressAddressLine1
1680 Michigan Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
dei Entity Address City Or Town
EntityAddressCityOrTown
Miami Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33139
dei City Area Code
CityAreaCode
(312)
dei Local Phone Number
LocalPhoneNumber
809-7002
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value per share
dei Trading Symbol
TradingSymbol
REFI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
true
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19634482
CY2024Q3 refi Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Investment
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossInvestment
338270022
CY2023Q4 refi Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Investment
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossInvestment
337238122
CY2024Q3 refi Loan Held For Investment Related Party
LoanHeldForInvestmentRelatedParty
16402488
CY2023Q4 refi Loan Held For Investment Related Party
LoanHeldForInvestmentRelatedParty
16402488
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
354672510
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
353640610
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
4090950
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
4972647
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
350581560
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
348667963
CY2024Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
6000000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6760433
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7898040
CY2024Q3 us-gaap Other Receivables
OtherReceivables
614762
CY2023Q4 us-gaap Other Receivables
OtherReceivables
705960
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
484361
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
1004140
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1471621
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107225
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
842269
CY2024Q3 us-gaap Assets
Assets
365912737
CY2023Q4 us-gaap Assets
Assets
359225597
CY2024Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
54000000
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
66000000
CY2024Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
9267714
CY2023Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
13866656
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
1570544
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
2051531
CY2024Q3 us-gaap Management Fee Payable
ManagementFeePayable
1669116
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
3243775
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1357718
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1135355
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2580887
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1074889
CY2024Q3 us-gaap Liabilities
Liabilities
70445979
CY2023Q4 us-gaap Liabilities
Liabilities
87372206
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19634482
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19634482
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18197192
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18197192
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
196345
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
181972
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
299721916
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
277483092
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4451503
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5811673
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
295466758
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
271853391
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
365912737
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
756536
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
284574
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24437565
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18740578
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1137607
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2986330
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7898040
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
359225597
CY2024Q3 us-gaap Interest Income Operating
InterestIncomeOperating
16258744
CY2023Q3 us-gaap Interest Income Operating
InterestIncomeOperating
15183450
us-gaap Interest Income Operating
InterestIncomeOperating
46624842
us-gaap Interest Income Operating
InterestIncomeOperating
46369976
CY2024Q3 us-gaap Interest Expense
InterestExpense
1799351
CY2023Q3 us-gaap Interest Expense
InterestExpense
1449143
us-gaap Interest Expense
InterestExpense
5742333
us-gaap Interest Expense
InterestExpense
4062365
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14459393
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
13734307
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
40882509
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
42307611
CY2024Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1669116
CY2023Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1601387
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
5198738
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
5539059
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1254062
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1251307
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3898864
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3833733
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
468652
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
491107
us-gaap Professional Fees
ProfessionalFees
1327659
us-gaap Professional Fees
ProfessionalFees
1598376
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
845524
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
540426
us-gaap Share Based Compensation
ShareBasedCompensation
2213150
us-gaap Share Based Compensation
ShareBasedCompensation
942605
CY2024Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-989597
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-41351
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-884789
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1193880
CY2024Q3 us-gaap Noninterest Expense
NoninterestExpense
3247757
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
3842876
us-gaap Noninterest Expense
NoninterestExpense
11753622
us-gaap Noninterest Expense
NoninterestExpense
13107653
CY2023Q3 refi Change In Unrealized Loss On Debt Securities At Fair Value
ChangeInUnrealizedLossOnDebtSecuritiesAtFairValue
-85567
refi Change In Unrealized Loss On Debt Securities At Fair Value
ChangeInUnrealizedLossOnDebtSecuritiesAtFairValue
75604
refi Change In Unrealized Loss On Debt Securities At Fair Value
ChangeInUnrealizedLossOnDebtSecuritiesAtFairValue
-112767
us-gaap Debt Securities Realized Gain Loss
DebtSecuritiesRealizedGainLoss
72428
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11211636
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9976998
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29125711
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29312725
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
11211636
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
9976998
us-gaap Net Income Loss
NetIncomeLoss
29125711
us-gaap Net Income Loss
NetIncomeLoss
29312725
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.6
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19625190
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18175467
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19094462
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18052293
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20058417
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18562930
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19531691
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18269171
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
292724905
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-46132
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
845524
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
9269175
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
11211636
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
295466758
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
273689874
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
540426
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.47
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
8421905
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
9976998
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
275785393
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
271853391
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20040214
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2213150
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.41
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
27765708
us-gaap Net Income Loss
NetIncomeLoss
29125711
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
295466758
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
264033023
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1222352
refi Stock Issued During Period Connection With Initial Public Offering And Concurrent Private Placement Net Of Offering Costs Underwritting Discount And Commission
StockIssuedDuringPeriodConnectionWithInitialPublicOfferingAndConcurrentPrivatePlacementNetOfOfferingCostsUnderwrittingDiscountAndCommission
5794847
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
942675
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.41
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
25520229
us-gaap Net Income Loss
NetIncomeLoss
29312725
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
275785393
us-gaap Net Income Loss
NetIncomeLoss
29125711
us-gaap Net Income Loss
NetIncomeLoss
29312725
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1311760
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1989374
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
7688284
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
6343749
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-884789
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1193880
refi Change In Unrealized Gainloss On Debt Securities Available For Sale At Fair Value
ChangeInUnrealizedGainlossOnDebtSecuritiesAvailableForSaleAtFairValue
75604
refi Change In Unrealized Gainloss On Debt Securities Available For Sale At Fair Value
ChangeInUnrealizedGainlossOnDebtSecuritiesAvailableForSaleAtFairValue
-112767
refi Realized Gain Loss On Debt Securities At Fair Value
RealizedGainLossOnDebtSecuritiesAtFairValue
72428
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
262361
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
405778
us-gaap Share Based Compensation
ShareBasedCompensation
2213150
us-gaap Share Based Compensation
ShareBasedCompensation
942605
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-519779
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1022490
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
58034
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
146364
refi Increase Decrease In Interest Reserves
IncreaseDecreaseInInterestReserves
1505998
refi Increase Decrease In Interest Reserves
IncreaseDecreaseInInterestReserves
-1369929
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-480987
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
271268
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1364396
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
3284900
us-gaap Increase Decrease In Debt Securities Trading
IncreaseDecreaseInDebtSecuritiesTrading
3356573
refi Proceeds From The Redemption Of Debt Securities At Fair Value
ProceedsFromTheRedemptionOfDebtSecuritiesAtFairValue
839094
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1574659
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1694213
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
225454
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
106839
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21331814
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12912736
refi Issuance Of And Fundings Of Loans Held For Investment
IssuanceOfAndFundingsOfLoansHeldForInvestment
75230855
refi Issuance Of And Fundings Of Loans Held For Investment
IssuanceOfAndFundingsOfLoansHeldForInvestment
67422648
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
64198999
us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
62837108
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
13000000
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
13399712
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1968144
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
8814172
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20796750
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7222363
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
73500000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
64000000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
85500000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
59000000
us-gaap Payments Of Dividends
PaymentsOfDividends
32364650
us-gaap Payments Of Dividends
PaymentsOfDividends
30566088
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
113129
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
112279
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
756536
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
284574
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24437565
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-18740578
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1137607
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2986330
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7898040
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5715827
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6760433
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8702157
refi Interest Reserve Withheld From Funding Of Loans
InterestReserveWithheldFromFundingOfLoans
4164021
refi Interest Reserve Withheld From Funding Of Loans
InterestReserveWithheldFromFundingOfLoans
1007910
refi Oid Withheld From Funding Of Loans Held For Investment
OIDWithheldFromFundingOfLoansHeldForInvestment
820335
refi Oid Withheld From Funding Of Loans Held For Investment
OIDWithheldFromFundingOfLoansHeldForInvestment
1676017
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9267714
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8568252
us-gaap Interest Paid Net
InterestPaidNet
5338916
us-gaap Interest Paid Net
InterestPaidNet
3530521
us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.90
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates in the Preparation of Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the provision for current expected credit losses.</span></p>
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6760433
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8702157
refi Interest Reserve Withheld From Funding Of Loans
InterestReserveWithheldFromFundingOfLoans
4164021
refi Interest Reserve Withheld From Funding Of Loans
InterestReserveWithheldFromFundingOfLoans
1007910
refi Oid Withheld From Funding Of Loans Held For Investment
OIDWithheldFromFundingOfLoansHeldForInvestment
820335
refi Oid Withheld From Funding Of Loans Held For Investment
OIDWithheldFromFundingOfLoansHeldForInvestment
1676017
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9267714
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8568252
us-gaap Mortgage Loan Related To Property Sales1
MortgageLoanRelatedToPropertySales1
19000000
us-gaap Mortgage Loan Related To Property Sales1
MortgageLoanRelatedToPropertySales1
13399712
us-gaap Interest Paid Net
InterestPaidNet
5338916
us-gaap Interest Paid Net
InterestPaidNet
3530521
us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.90
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates in the Preparation of Consolidated Financial Statements</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the provision for current expected credit losses.</span></p>
us-gaap Revenue Recognition Interest
RevenueRecognitionInterest
<p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Revenue Recognition</span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Interest </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">income on debt securities designated as trading securities is recognized on an accrual basis and is reported as interest receivable until collected. Interest income is accrued based on the outstanding face amount and the contractual terms of the securities. Original issue discount (“OID”), market discounts or premiums, if any, are recorded as an adjustment to the amortized cost and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">accreted </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">or amortized as an adjustment to interest income using a method that approximates the effective interest method. Realized gains or losses on debt securities are measured by the difference between the net proceeds from the disposition and the amortized and/or accreted cost basis of the investment using the specific identification method without regard to unrealized gains or losses previously recognized, and include loans charged off during the period, net of recoveries.</span></p>
refi Principal Gross Fundings
PrincipalGrossFundings
76100000
CY2024Q3 refi Portfolio Percentage
PortfolioPercentage
0.622
refi Principal Gross Fundings
PrincipalGrossFundings
76100000
CY2023Q4 refi Portfolio Percentage
PortfolioPercentage
0.805
CY2024Q3 us-gaap Debt Current
DebtCurrent
220200000
CY2023Q4 us-gaap Debt Current
DebtCurrent
284500000
CY2024Q3 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.378
CY2023Q4 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.195
CY2024Q3 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
134500000
CY2023Q4 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
69100000
CY2024Q3 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
356285780
CY2024Q3 refi Senior Term Loans Original Issue Discount
SeniorTermLoansOriginalIssueDiscount
-1613270
CY2024Q3 refi Senior Term Loans Principal
SeniorTermLoansPrincipal
354672510
us-gaap Financing Receivable Modified Weighted Average Term Increase From Modification
FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification
P2Y1M6D
CY2024Q3 refi Current Expected Credit Loss Reserve Principal
CurrentExpectedCreditLossReservePrincipal
0
CY2024Q3 refi Current Expected Credit Loss Reserve Original Discount
CurrentExpectedCreditLossReserveOriginalDiscount
0
CY2024Q3 refi Current Expected Credit Loss Reserve Carrying Values
CurrentExpectedCreditLossReserveCarryingValues
4090950
CY2024Q3 us-gaap Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
356285780
CY2024Q3 refi Loans Held At Original Issue Discount
LoansHeldAtOriginalIssueDiscount
-1613270
CY2024Q3 refi Loans Held At Principal Value
LoansHeldAtPrincipalValue
350581560
CY2023Q4 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
355745305
CY2023Q4 refi Senior Term Loans Original Issue Discount
SeniorTermLoansOriginalIssueDiscount
-2104695
CY2023Q4 refi Senior Term Loans Principal
SeniorTermLoansPrincipal
353640610
CY2023 us-gaap Financing Receivable Modified Weighted Average Term Increase From Modification
FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification
P2Y1M6D
CY2023Q4 refi Current Expected Credit Loss Reserve Principal
CurrentExpectedCreditLossReservePrincipal
0
CY2023Q4 refi Current Expected Credit Loss Reserve Original Discount
CurrentExpectedCreditLossReserveOriginalDiscount
0
CY2023Q4 refi Current Expected Credit Loss Reserve Carrying Values
CurrentExpectedCreditLossReserveCarryingValues
4972647
CY2023Q4 us-gaap Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
355745305
CY2023Q4 refi Loans Held At Original Issue Discount
LoansHeldAtOriginalIssueDiscount
-2104695
CY2023Q4 refi Loans Held At Principal Value
LoansHeldAtPrincipalValue
348667963
CY2023Q4 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
348667963
refi New Fundings
NewFundings
75230855
refi Principal Repayment Of Loans And Principal Receivables
PrincipalRepaymentOfLoansAndPrincipalReceivables
64198999
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1311760
refi Transfer Of Loan Held For Investment To Loan Held For Sale
TransferOfLoanHeldForInvestmentToLoanHeldForSale
-18786087
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
7688284
CY2023Q4 refi Portfolio Percentage
PortfolioPercentage
0.805
CY2024Q3 us-gaap Debt Current
DebtCurrent
220200000
CY2023Q4 us-gaap Debt Current
DebtCurrent
284500000
CY2024Q3 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.378
CY2023Q4 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.195
CY2024Q3 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
134500000
CY2023Q4 us-gaap Loans Receivable With Fixed Rates Of Interest1
LoansReceivableWithFixedRatesOfInterest1
69100000
CY2024Q3 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
356285780
CY2024Q3 refi Senior Term Loans Original Issue Discount
SeniorTermLoansOriginalIssueDiscount
-1613270
CY2024Q3 refi Senior Term Loans Principal
SeniorTermLoansPrincipal
354672510
us-gaap Financing Receivable Modified Weighted Average Term Increase From Modification
FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification
P2Y1M6D
CY2024Q3 refi Current Expected Credit Loss Reserve Principal
CurrentExpectedCreditLossReservePrincipal
0
CY2024Q3 refi Current Expected Credit Loss Reserve Original Discount
CurrentExpectedCreditLossReserveOriginalDiscount
0
CY2024Q3 refi Current Expected Credit Loss Reserve Carrying Values
CurrentExpectedCreditLossReserveCarryingValues
4090950
CY2024Q3 us-gaap Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
356285780
CY2024Q3 refi Loans Held At Original Issue Discount
LoansHeldAtOriginalIssueDiscount
-1613270
CY2024Q3 refi Loans Held At Principal Value
LoansHeldAtPrincipalValue
350581560
CY2023Q4 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
355745305
CY2023Q4 refi Senior Term Loans Original Issue Discount
SeniorTermLoansOriginalIssueDiscount
-2104695
CY2023Q4 refi Senior Term Loans Principal
SeniorTermLoansPrincipal
353640610
CY2023 us-gaap Financing Receivable Modified Weighted Average Term Increase From Modification
FinancingReceivableModifiedWeightedAverageTermIncreaseFromModification
P2Y1M6D
CY2023Q4 refi Current Expected Credit Loss Reserve Principal
CurrentExpectedCreditLossReservePrincipal
0
CY2023Q4 refi Current Expected Credit Loss Reserve Original Discount
CurrentExpectedCreditLossReserveOriginalDiscount
0
CY2023Q4 refi Current Expected Credit Loss Reserve Carrying Values
CurrentExpectedCreditLossReserveCarryingValues
4972647
CY2023Q4 us-gaap Principal Amount Outstanding Of Loans Held In Portfolio
PrincipalAmountOutstandingOfLoansHeldInPortfolio
355745305
CY2023Q4 refi Loans Held At Original Issue Discount
LoansHeldAtOriginalIssueDiscount
-2104695
CY2023Q4 refi Loans Held At Principal Value
LoansHeldAtPrincipalValue
348667963
CY2023Q4 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
348667963
refi New Fundings
NewFundings
75230855
refi Principal Repayment Of Loans And Principal Receivables
PrincipalRepaymentOfLoansAndPrincipalReceivables
64198999
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1311760
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
667784
CY2024Q3 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
350581560
CY2022Q4 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
335332599
refi New Fundings
NewFundings
67422648
refi Principal Repayment Of Loans And Principal Receivables
PrincipalRepaymentOfLoansAndPrincipalReceivables
62837108
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1989374
CY2023Q3 refi Principal Sale Of Loans
PrincipalSaleOfLoans
13399712
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
6343749
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-1171256
CY2023Q3 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
333680294
refi Outstanding Principal
OutstandingPrincipal
356285780
refi Original Issue Premium Discount
OriginalIssuePremiumDiscount
-1613270
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
667784
CY2024Q3 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
350581560
CY2022Q4 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
335332599
refi New Fundings
NewFundings
67422648
refi Principal Repayment Of Loans And Principal Receivables
PrincipalRepaymentOfLoansAndPrincipalReceivables
62837108
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1989374
CY2023Q3 refi Principal Sale Of Loans
PrincipalSaleOfLoans
13399712
us-gaap Interest Income Operating Paid In Kind
InterestIncomeOperatingPaidInKind
6343749
us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
-1171256
CY2023Q3 refi Loan Held At Carrying Value Balance
LoanHeldAtCarryingValueBalance
333680294
refi Outstanding Principal
OutstandingPrincipal
356285780
refi Original Issue Premium Discount
OriginalIssuePremiumDiscount
-1613270
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
354672510
refi Percentof Our Loan Portfolio
PercentofOurLoanPortfolio
1
refi Future Fundings
FutureFundings
6000000
refi Yieldto Maturityof Internal Rateof Return
YieldtoMaturityofInternalRateofReturn
0.182
CY2024Q3 refi Unfunded Commitment Annual Rate
UnfundedCommitmentAnnualRate
0.012
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
354672510
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
354672510
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
353640610
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
353640610
CY2024Q3 us-gaap Loans Payable
LoansPayable
1
CY2023Q4 us-gaap Loans Payable
LoansPayable
2
CY2024Q3 refi Financing Receivable Excluding Accrued Interest Year One Remainding Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneRemaindingFiscalYear
73089078
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
71473482
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
122540755
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
87569195
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
354672510
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
54606866
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
149948641
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
149085103
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
353640610
CY2024Q3 refi Real Estate Collaterals Coverage
RealEstateCollateralsCoverage
354672510
CY2023Q4 refi Real Estate Collaterals Coverage
RealEstateCollateralsCoverage
353640610
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss Current
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
354672510
refi Percentof Our Loan Portfolio
PercentofOurLoanPortfolio
1
refi Future Fundings
FutureFundings
6000000
refi Yieldto Maturityof Internal Rateof Return
YieldtoMaturityofInternalRateofReturn
0.182
CY2024Q3 refi Unfunded Commitment Annual Rate
UnfundedCommitmentAnnualRate
0.012
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
354672510
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
354672510
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
353640610
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
353640610
CY2024Q3 us-gaap Loans Payable
LoansPayable
1
CY2024Q3 refi Financing Receivable Excluding Accrued Interest Year One Remainding Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneRemaindingFiscalYear
73089078
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
71473482
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
122540755
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
87569195
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
354672510
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
54606866
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
149948641
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
149085103
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
353640610
CY2024Q3 refi Real Estate Collaterals Coverage
RealEstateCollateralsCoverage
354672510
CY2023Q4 refi Real Estate Collaterals Coverage
RealEstateCollateralsCoverage
353640610
CY2024Q3 refi Number Of Loans
NumberOfLoans
3
CY2024Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
600000
CY2024Q2 refi Loans And Leases Receivable Gross Contribution Amount
LoansAndLeasesReceivableGrossContributionAmount
600000
CY2024Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1000000
CY2023Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
4975739
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-884789
CY2024Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
4090950
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
4035354
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1193880
CY2023Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
0
CY2023Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
0
CY2024Q3 refi Number Of Loans
NumberOfLoans
3
CY2024Q3 refi Principal Repayment Of Loans And Principal Receivables
PrincipalRepaymentOfLoansAndPrincipalReceivables
300000
CY2024Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
600000
CY2024Q2 refi Loans And Leases Receivable Gross Contribution Amount
LoansAndLeasesReceivableGrossContributionAmount
600000
CY2024Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-1000000
CY2023Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
4975739
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-884789
CY2024Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
4090950
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
4035354
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1193880
CY2023Q3 us-gaap Loans And Leases Receivable Gross Carrying Amount Covered
LoansAndLeasesReceivableGrossCarryingAmountCovered
5229234
CY2023Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
0
CY2023Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
0
CY2023Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
0
refi Transfer Of Loans Held For Investment To Loans Held For Sale
TransferOfLoansHeldForInvestmentToLoansHeldForSale
19000000
us-gaap Payments For Loans
PaymentsForLoans
0
refi Accretion Of Original Issue Discount
AccretionOfOriginalIssueDiscount
0
refi Principal Sale Of Loan
PrincipalSaleOfLoan
13000000
CY2024Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
6000000
CY2024Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
6000000
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
477961
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
973140
CY2024Q3 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
6400
CY2023Q4 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
31000
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
484361
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
1004140
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
484361
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
484361
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
1004140
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
1004140
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
16300000
us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
0
CY2023Q4 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
0
refi Transfer Of Loans Held For Investment To Loans Held For Sale
TransferOfLoansHeldForInvestmentToLoansHeldForSale
19000000
us-gaap Payments For Loans
PaymentsForLoans
0
refi Accretion Of Original Issue Discount
AccretionOfOriginalIssueDiscount
0
refi Principal Sale Of Loan
PrincipalSaleOfLoan
13000000
CY2024Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
6000000
CY2024Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
6000000
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
477961
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
973140
CY2024Q3 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
6400
CY2023Q4 us-gaap Accrued Fees And Other Revenue Receivable
AccruedFeesAndOtherRevenueReceivable
31000
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
484361
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
1004140
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
484361
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
484361
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
1004140
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
1004140
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
16300000
us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
0
CY2023Q4 refi Interest Reserves
InterestReserves
1074889
CY2022Q4 refi Interest Reserves
InterestReserves
1868193
refi New Reserves
NewReserves
4164021
CY2023 refi New Reserves
NewReserves
2238348
refi Reserve Disbursed
ReserveDisbursed
2658023
CY2023 refi Reserve Disbursed
ReserveDisbursed
3031652
CY2024Q3 refi Interest Reserves
InterestReserves
2580887
CY2023Q4 refi Interest Reserves
InterestReserves
1074889
CY2024Q3 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
100000
CY2023Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
2988
CY2023Q4 refi Interest Reserves
InterestReserves
1074889
CY2022Q4 refi Interest Reserves
InterestReserves
1868193
refi New Reserves
NewReserves
4164021
CY2023 refi New Reserves
NewReserves
2238348
refi Reserve Disbursed
ReserveDisbursed
2658023
CY2023 refi Reserve Disbursed
ReserveDisbursed
3031652
CY2024Q3 refi Interest Reserves
InterestReserves
2580887
CY2023Q4 refi Interest Reserves
InterestReserves
1074889
CY2024Q3 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
100000
CY2023Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
2988
refi Debt Instrument Covenants Maximum Capital Expenditures
DebtInstrumentCovenantsMaximumCapitalExpenditures
150000
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
261217
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
366592
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-12000000
us-gaap Financing Receivable Revolving Converted To Term Loan During Period
FinancingReceivableRevolvingConvertedToTermLoanDuringPeriod
56000000
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1701480
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1276292
us-gaap Interest Expense Debt
InterestExpenseDebt
5454281
us-gaap Interest Expense Debt
InterestExpenseDebt
3588712
refi Debt Instrument Covenants Maximum Capital Expenditures
DebtInstrumentCovenantsMaximumCapitalExpenditures
150000
CY2024Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
261217
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
366592
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-12000000
us-gaap Financing Receivable Revolving Converted To Term Loan During Period
FinancingReceivableRevolvingConvertedToTermLoanDuringPeriod
56000000
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1701480
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1276292
us-gaap Interest Expense Debt
InterestExpenseDebt
5454281
us-gaap Interest Expense Debt
InterestExpenseDebt
3588712
CY2024Q3 refi Unused Fee Expense
UnusedFeeExpense
18104
CY2023Q3 refi Unused Fee Expense
UnusedFeeExpense
26174
refi Unused Fee Expense
UnusedFeeExpense
25691
refi Unused Fee Expense
UnusedFeeExpense
67875
CY2024Q3 refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
79767
CY2023Q3 refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
146677
refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
262361
refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
405778
CY2024Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-1799351
CY2023Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-1449143
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-5742333
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-4062365
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
54000000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
54000000
us-gaap Management Fee Description
ManagementFeeDescription
The Manager is entitled to receive base management fees (the “Base Management Fee”) that are calculated and payable quarterly in arrears, in an amount equal to 0.375% of the Company’s Equity, determined as of the last day of each such quarter; reduced by an amount equal to 50% of the pro rata amount of origination fees earned and paid to the Manager during the applicable quarter for loans that were originated on the Company’s behalf by the Manager or affiliates of the Manager (“Outside Fees”).
CY2024Q3 refi Unused Fee Expense
UnusedFeeExpense
18104
CY2023Q3 refi Unused Fee Expense
UnusedFeeExpense
26174
refi Unused Fee Expense
UnusedFeeExpense
25691
refi Unused Fee Expense
UnusedFeeExpense
67875
CY2024Q3 refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
79767
CY2023Q3 refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
146677
refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
262361
refi Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
405778
CY2024Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-1799351
CY2023Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-1449143
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-5742333
us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-4062365
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
54000000
CY2024Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
54000000
us-gaap Management Fee Description
ManagementFeeDescription
The Manager is entitled to receive base management fees (the “Base Management Fee”) that are calculated and payable quarterly in arrears, in an amount equal to 0.375% of the Company’s Equity, determined as of the last day of each such quarter; reduced by an amount equal to 50% of the pro rata amount of origination fees earned and paid to the Manager during the applicable quarter for loans that were originated on the Company’s behalf by the Manager or affiliates of the Manager (“Outside Fees”).
us-gaap Management And Service Fees Base Rate
ManagementAndServiceFeesBaseRate
0.00375
refi Prorata Percentage Reduction On Base Management Fee
ProrataPercentageReductionOnBaseManagementFee
0.50
CY2024Q3 refi Outside Fees Earned
OutsideFeesEarned
60000
refi Outside Fees Earned
OutsideFeesEarned
91571
CY2023Q3 refi Outside Fees Earned
OutsideFeesEarned
0
refi Outside Fees Earned
OutsideFeesEarned
130000
CY2024Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
606737
CY2023Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
545966
us-gaap Incentive Fee Expense
IncentiveFeeExpense
1986008
us-gaap Incentive Fee Expense
IncentiveFeeExpense
2532026
CY2024Q3 refi Management Fees Earned
ManagementFeesEarned
1122379
CY2023Q3 refi Management Fees Earned
ManagementFeesEarned
1055421
refi Management Fees Earned
ManagementFeesEarned
3304301
refi Management Fees Earned
ManagementFeesEarned
3137033
CY2024Q3 refi Outside Fees Earned
OutsideFeesEarned
60000
CY2023Q3 refi Outside Fees Earned
OutsideFeesEarned
0
refi Outside Fees Earned
OutsideFeesEarned
91571
refi Outside Fees Earned
OutsideFeesEarned
130000
CY2024Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1062379
us-gaap Management And Service Fees Base Rate
ManagementAndServiceFeesBaseRate
0.00375
refi Prorata Percentage Reduction On Base Management Fee
ProrataPercentageReductionOnBaseManagementFee
0.50
CY2024Q3 refi Outside Fees Earned
OutsideFeesEarned
60000
refi Outside Fees Earned
OutsideFeesEarned
91571
CY2023Q3 refi Outside Fees Earned
OutsideFeesEarned
0
refi Outside Fees Earned
OutsideFeesEarned
130000
CY2024Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
606737
CY2023Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
545966
us-gaap Incentive Fee Expense
IncentiveFeeExpense
1986008
us-gaap Incentive Fee Expense
IncentiveFeeExpense
2532026
CY2024Q3 refi Management Fees Earned
ManagementFeesEarned
1122379
CY2023Q3 refi Management Fees Earned
ManagementFeesEarned
1055421
refi Management Fees Earned
ManagementFeesEarned
3304301
refi Management Fees Earned
ManagementFeesEarned
3137033
CY2024Q3 refi Outside Fees Earned
OutsideFeesEarned
60000
CY2023Q3 refi Outside Fees Earned
OutsideFeesEarned
0
refi Outside Fees Earned
OutsideFeesEarned
91571
refi Outside Fees Earned
OutsideFeesEarned
130000
CY2024Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1062379
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1055421
us-gaap Management Fee Expense
ManagementFeeExpense
3212730
us-gaap Management Fee Expense
ManagementFeeExpense
3007033
CY2024Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
606737
CY2023Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
545966
us-gaap Incentive Fee Expense
IncentiveFeeExpense
1986008
us-gaap Incentive Fee Expense
IncentiveFeeExpense
2532026
CY2024Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1669116
CY2023Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1601387
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
5198738
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
5539059
CY2024Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1110611
CY2023Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1144907
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
3455367
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
3533493
CY2024Q3 us-gaap Affiliate Costs
AffiliateCosts
2779727
CY2023Q3 us-gaap Affiliate Costs
AffiliateCosts
2746294
us-gaap Affiliate Costs
AffiliateCosts
8654105
us-gaap Affiliate Costs
AffiliateCosts
9072552
us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
2800000
CY2023 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
5300000
CY2024Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
700000
CY2023Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1200000
refi Assigned Right Sold Amount
AssignedRightSoldAmount
600000
refi Assigned Right Sold Amount
AssignedRightSoldAmount
200000
CY2023Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
19300000
CY2023Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
19000000
us-gaap Selling Expense
SellingExpense
14200000
CY2023Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1055421
us-gaap Management Fee Expense
ManagementFeeExpense
3212730
CY2023Q3 us-gaap Incentive Fee Expense
IncentiveFeeExpense
545966
us-gaap Incentive Fee Expense
IncentiveFeeExpense
1986008
us-gaap Incentive Fee Expense
IncentiveFeeExpense
2532026
CY2024Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1669116
CY2023Q3 refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
1601387
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
5198738
refi Management And Incentive Fees Payable
ManagementAndIncentiveFeesPayable
5539059
CY2024Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1110611
CY2023Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1144907
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
3455367
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
3533493
CY2024Q3 us-gaap Affiliate Costs
AffiliateCosts
2779727
CY2023Q3 us-gaap Affiliate Costs
AffiliateCosts
2746294
us-gaap Affiliate Costs
AffiliateCosts
8654105
us-gaap Affiliate Costs
AffiliateCosts
9072552
us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
2800000
CY2023 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
5300000
CY2024Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
700000
CY2023Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1200000
refi Assigned Right Sold Amount
AssignedRightSoldAmount
600000
refi Assigned Right Sold Amount
AssignedRightSoldAmount
200000
CY2023Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
19300000
CY2023Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
19000000
us-gaap Selling Expense
SellingExpense
14200000
CY2024Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
13400000
CY2024Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
6000000
CY2024Q3 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
0
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
16400000
CY2024Q3 refi Original Loan Commitments
OriginalLoanCommitments
399706770
CY2024Q3 refi Less Drawn Commitments
LessDrawnCommitments
393706770
CY2023Q4 refi Less Drawn Commitments
LessDrawnCommitments
371349998
CY2024Q3 refi Undrawn Commitments
UndrawnCommitments
6000000
CY2023Q4 refi Undrawn Commitments
UndrawnCommitments
7500000
CY2024Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
13400000
CY2024Q3 us-gaap Loans Held For Sale Fair Value Disclosure
LoansHeldForSaleFairValueDisclosure
6000000
CY2024Q3 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
0
CY2024Q3 us-gaap Loans Payable Current
LoansPayableCurrent
16400000
CY2024Q3 refi Original Loan Commitments
OriginalLoanCommitments
399706770
CY2023Q4 refi Original Loan Commitments
OriginalLoanCommitments
378849998
CY2024Q3 refi Less Drawn Commitments
LessDrawnCommitments
393706770
CY2023Q4 refi Less Drawn Commitments
LessDrawnCommitments
371349998
CY2024Q3 refi Undrawn Commitments
UndrawnCommitments
6000000
CY2023Q4 refi Undrawn Commitments
UndrawnCommitments
7500000
CY2024Q3 us-gaap Other Commitment
OtherCommitment
6000000
CY2024Q3 us-gaap Other Commitments Future Minimum Payments Remainder Of Fiscal Year
OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear
6000000
CY2024Q3 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
0
CY2024Q3 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
0
CY2024Q3 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
0
CY2024Q3 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
0
CY2024Q3 us-gaap Other Commitment Due In Fifth Year
OtherCommitmentDueInFifthYear
0
us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
1147
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
6611324
CY2024Q3 us-gaap Other Commitment
OtherCommitment
6000000
CY2024Q3 us-gaap Other Commitments Future Minimum Payments Remainder Of Fiscal Year
OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear
6000000
CY2024Q3 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
0
CY2024Q3 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
0
CY2024Q3 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
0
CY2024Q3 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
0
CY2024Q3 us-gaap Other Commitment Due In Fifth Year
OtherCommitmentDueInFifthYear
0
us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
0
us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
1147
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
6611324
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
2935112
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
5525370
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
937068
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
366647
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.86
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
187335
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.59
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
426262
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
15.17
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
80984
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
323452
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
16
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
refi Unamortized Share Based Compensation Expense
UnamortizedShareBasedCompensationExpense
5200000
refi Unamortized Share Based Compensation Expense
UnamortizedShareBasedCompensationExpense
5100000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
2935112
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
5525370
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
937068
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
366647
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.86
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
187335
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
127720
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
14.89
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
426262
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
15.17
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
80984
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
15.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
323452
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
20648
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
16
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
1147
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
16
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
382641
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.88
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2200000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
900000
refi Unamortized Share Based Compensation Expense
UnamortizedShareBasedCompensationExpense
5200000
refi Unamortized Share Based Compensation Expense
UnamortizedShareBasedCompensationExpense
5100000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y
CY2023Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
75000000
refi Gross Proceeds Percentage
grossProceedsPercentage
0.03
CY2024Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
11211636
CY2023Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
9976998
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
29125711
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
29312725
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19625190
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18175467
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19094462
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18052293
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18562930
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19531691
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18269171
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2024Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
11211636
CY2023Q3 us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
9976998
us-gaap Net Income Loss From Discontinued Operations Available To Common Shareholders Basic
NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
29312725
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19625190
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18052293
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20058417
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18562930
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19531691
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18269171
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.6
us-gaap Income Tax Holiday Description
IncomeTaxHolidayDescription
To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement that we distribute annually to our stockholders at least 90% of our REIT taxable income prior to the deduction for dividends paid. To the extent that we distribute less than 100% of our REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), we will pay tax at regular corporate rates on that undistributed portion. Furthermore, if we distribute less than the sum of 1) 85% of our ordinary income for the calendar year, 2) 95% of our capital gain net income for the calendar year, and 3) any undistributed shortfall from our prior calendar year (the “Required Distribution”) to our stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then we are required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if we elect to retain any of our net capital gain for any tax year, we must notify our stockholders and pay tax at regular corporate rates on the retained net capital gain. Our stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax.
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
353727754
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
351952876
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-944756
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1687734
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.6
us-gaap Income Tax Holiday Description
IncomeTaxHolidayDescription
To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement that we distribute annually to our stockholders at least 90% of our REIT taxable income prior to the deduction for dividends paid. To the extent that we distribute less than 100% of our REIT taxable income in any tax year (taking into account any distributions made in a subsequent tax year under Sections 857(b)(9) or 858 of the Code), we will pay tax at regular corporate rates on that undistributed portion. Furthermore, if we distribute less than the sum of 1) 85% of our ordinary income for the calendar year, 2) 95% of our capital gain net income for the calendar year, and 3) any undistributed shortfall from our prior calendar year (the “Required Distribution”) to our stockholders during any calendar year (including any distributions declared by the last day of the calendar year but paid in the subsequent year), then we are required to pay a non-deductible excise tax equal to 4% of any shortfall between the Required Distribution and the amount that was actually distributed. The 90% distribution requirement does not require the distribution of net capital gains. However, if we elect to retain any of our net capital gain for any tax year, we must notify our stockholders and pay tax at regular corporate rates on the retained net capital gain. Our stockholders must include their proportionate share of the retained net capital gain in their taxable income for the tax year, and they are deemed to have paid the REIT’s tax on their proportionate share of the retained capital gain. Furthermore, such retained capital gain may be subject to the nondeductible 4% excise tax.
CY2024Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
353727754
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
351952876
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-944756
CY2023 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1687734
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
refi Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
refi Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
refi Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
refi Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-122763-index-headers.html Edgar Link pending
0000950170-24-122763-index.html Edgar Link pending
0000950170-24-122763.txt Edgar Link pending
0000950170-24-122763-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
refi-20240930.htm Edgar Link pending
refi-20240930.xsd Edgar Link pending
refi-ex31_1.htm Edgar Link pending
refi-ex31_2.htm Edgar Link pending
refi-ex32_1.htm Edgar Link pending
refi-ex32_2.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
refi-20240930_htm.xml Edgar Link completed